Phosphorylation Codes in IRS-1 and IRS-2 Are Associated with the Activation/Inhibition of Insulin Canonical Signaling Pathways

• Published in: Current Issues in Molecular Biology Vol. 46; no. 1; pp. 634 - 649
• Main Authors: Martínez Báez, Anabel, Ayala, Guadalupe, Pedroza-Saavedra, Adolfo, González-Sánchez, Hilda M., Chihu Amparan, Lilia
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.01.2024
• Subjects: Cellular signal transduction; Cytokines; Insulin; Integrins; IRS-1; IRS-2; phosphorylation; Steroid hormones; Taxation; Tyrosine; IRS-2; insulin; IRS-1; phosphorylation
• ISSN: 1467-3045; 1467-3037; 1467-3045
• DOI: 10.3390/cimb46010041

Insulin receptor substrates 1 and 2 (IRS-1 and IRS-2) are signaling adaptor proteins that participate in canonical pathways, where insulin cascade activation occurs, as well as in non-canonical pathways, in which phosphorylation of substrates is carried out by a diverse array of receptors including integrins, cytokines, steroid hormones, and others. IRS proteins are subject to a spectrum of post-translational modifications essential for their activation, encompassing phosphorylation events in distinct tyrosine, serine, and threonine residues. Tyrosine residue phosphorylation is intricately linked to the activation of the insulin receptor cascade and its interaction with SH2 domains within a spectrum of proteins, including PI3K. Conversely, serine residue phosphorylation assumes a different function, serving to attenuate the effects of insulin. In this review, we have identified over 50 serine residues within IRS-1 that have been reported to undergo phosphorylation orchestrated by a spectrum of kinases, thereby engendering the activation or inhibition of different signaling pathways. Furthermore, we delineate the phosphorylation of over 10 distinct tyrosine residues at IRS-1 or IRS-2 in response to insulin, a process essential for signal transduction and the subsequent activation of PI3K.